Lowest Price Guaranteed
Pages
159
Last Updated
June 2026
View Count
13508
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Glycated Haemoglobin Testing
6.2.1. Key Characteristics Glycated Haemoglobin Testing
6.2.2. Advantages of Glycated Haemoglobin Testing
6.2.3. Challenges Associated with Glycated Haemoglobin Testing
6.3. Future Perspective
7. REGULATORY SCENARIO
8. COMPREHENSIVE DATABASE OF LEADING PLAYERS
9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. Glycated Haemoglobin Testing: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. Glycated Haemoglobin Testing Market: Overall Market Landscape
9.2.4.1. Analysis by Test Type
9.2.4.2. Analysis by Test Method Type
9.2.4.3. Analysis by Application Area
9.2.4.4. Analysis by Distribution Channel
9.2.4.5. Analysis by End User
10. COMPETITIVE COMPETITIVENESS ANALYSIS
11. STARTUP ECOSYSTEM IN THE GLYCATED HAEMOGLOBIN TESTING MARKET
11.1. Glycated Haemoglobin Testing: Market Landscape of Startups
11.1.1. Analysis by Year of Establishment
11.1.2. Analysis by Company Size
11.1.3. Analysis by Company Size and Year of Establishment
11.1.4. Analysis by Location of Headquarters
11.1.5. Analysis by Company Size and Location of Headquarters
11.1.6. Analysis by Ownership Structure
11.2. Key Findings
12. COMPANY PROFILES
12.1. Chapter Overview
12.2. Abbott (US)
12.2.1. Company Overview
12.2.2. Company Mission
12.2.3. Company Footprint
12.2.4. Management Team
12.2.5. Contact Details
12.2.6. Financial Performance
12.2.7. Operating Business Segments
12.2.8. Product Portfolio
12.2.9. MOAT Analysis
12.2.10. Recent Developments and Future Outlook
* similar detail is presented for other below mentioned companies based on information in the public domain
12.3. Bio-Rad Laboratories (China)
12.4. Ceragem Medisys (South Korea)
12.5. HUMAN (HUMAN Diagnostics, Germany)
12.6. Menarini Diagnostics (Italy)
12.7. SAKAE (JAPAN)
12.8. SEKISUI MEDICAL (Japan)
12.9. Siemens Healthineers (Germany)
12.10. Trinity Biotech (Ireland)
13. PORTER'S FIVE FORCES ANALYSIS
14. PARTNERSHIPS AND COLLABORATIONS
14.1. Chapter Overview
14.2. Partnership Models
14.3. Glycated Haemoglobin Testing: Partnerships and Collaborations
14.3.1. Analysis by Year of Partnership
14.3.2. Analysis by Type of Partnership
14.3.3. Analysis by Year and Type of Partnership
14.3.4. Analysis by Type of Partner
14.3.5. Analysis by Location of Headquarters of Partner
14.3.6. Analysis by Type of Partnership and Location of Headquarters of Partner
14.3.7. Most Active Players: Analysis by Number of Partnerships
14.3.8. Regional Analysis
15. FUNDING AND INVESTMENTS ANALYSIS
15.1. Funding Models
15.2. Glycated Haemoglobin Testing: Funding and Investments
15.2.1. Analysis by Year of Funding
15.2.2. Analysis of Funding Instances by Type of Funding
15.2.3. Analysis of Funding Instances by Year and Type of Funding
15.2.4. Analysis of Amount Invested by Type of Funding
15.2.5. Analysis of Funding Instances by Country
15.2.6. Most Active Players: Analysis by Amount Raised
15.3. Summary and Key Takeaways
16. GLOBAL GLYCATED HAEMOGLOBIN TESTING MARKET
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Trends Disruption Impacting Market
16.4. Demand Side Trends
16.5. Supply Side Trends
16.6. Global Glycated Haemoglobin Testing Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. Multivariate Scenario Analysis
16.7.1. Conservative Scenario
16.7.2. Optimistic Scenario
16.8. Investment Feasibility Index
16.9. Key Market Segmentations
17. MARKET OPPORTUNITIES BASED ON TYPE OF TEST
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Glycated Haemoglobin Testing Market for Laboratory-Based Testing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. Glycated Haemoglobin Testing Market for Point-of-Care (POC) Testing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.8. Data Triangulation and Validation
17.8.1. Secondary Sources
17.8.2. Primary Sources
17.8.3. Statistical Modeling
18. MARKET OPPORTUNITIES BASED ON TYPE OF TEST METHOD
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Glycated Haemoglobin Testing Market for Immunoassays: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. Glycated Haemoglobin Testing Market for Enzymatic Assays: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.8. Glycated Haemoglobin Testing Market for Boronate Affinity Chormatography: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.9. Glycated Haemoglobin Testing Market for High-Performance Liquid Chromatography: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.10. Glycated Haemoglobin Testing Market for Capillary Electrophoresis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.11. Glycated Haemoglobin Testing Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.12. Data Triangulation and Validation
18.12.1. Secondary Sources
18.12.2. Primary Sources
18.12.3. Statistical Modeling
19. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. Glycated Haemoglobin Testing Market for Diabetes Monitoring: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7. Glycated Haemoglobin Testing Market for Gestational Diabetes Management: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.8. Glycated Haemoglobin Testing Market for Chronic Conditions Management: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.9. Data Triangulation and Validation
19.9.1. Secondary Sources
19.9.2. Primary Sources
19.9.3. Statistical Modeling
20. MARKET OPPORTUNITIES BASED ON DISTRIBUTION CHANNEL
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. Glycated Haemoglobin Testing Market for Direct Sales: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.7. Glycated Haemoglobin Testing Market for Distributors and Third-Party Vendors: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.8. Glycated Haemoglobin Testing Market for Online Retailers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.9. Glycated Haemoglobin Testing Market for Pharmacies and Drug Stores: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.10. Data Triangulation and Validation
20.10.1. Secondary Sources
20.10.2. Primary Sources
20.10.3. Statistical Modeling
21. MARKET OPPORTUNITIES BASED ON END USER
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix
21.6. Glycated Haemoglobin Testing Market for Hospitals & Clinics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.7. Glycated Haemoglobin Testing Market for Diagnostic Laboratories: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.8. Glycated Haemoglobin Testing Market for Homecare Settings: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.9. Data Triangulation and Validation
21.9.1. Secondary Sources
21.9.2. Primary Sources
21.9.3. Statistical Modeling
22. MARKET OPPORTUNITIES FOR GLYCATED HAEMOGLOBIN TESTING IN NORTH AMERICA
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix
22.6. Glycated Haemoglobin Testing Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.1. Glycated Haemoglobin Testing Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.2. Glycated Haemoglobin Testing Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.3. Glycated Haemoglobin Testing Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.7. Data Triangulation and Validation
23. MARKET OPPORTUNITIES FOR GLYCATED HAEMOGLOBIN TESTING IN EUROPE
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix
23.6. Glycated Haemoglobin Testing Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.1. Glycated Haemoglobin Testing Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.2. Glycated Haemoglobin Testing Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.3. Glycated Haemoglobin Testing Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.4. Glycated Haemoglobin Testing Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.5. Glycated Haemoglobin Testing Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.6. Glycated Haemoglobin Testing Market in Rest of the Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.7. Data Triangulation and Validation
24. MARKET OPPORTUNITIES FOR GLYCATED HAEMOGLOBIN TESTING IN ASIA-PACIFIC
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix
24.6. Glycated Haemoglobin Testing Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.1. Glycated Haemoglobin Testing Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.2. Glycated Haemoglobin Testing Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.3. Glycated Haemoglobin Testing Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.4. Glycated Haemoglobin Testing Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.5. Glycated Haemoglobin Testing Market in New Zealand: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.6. Glycated Haemoglobin Testing Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.7. Data Triangulation and Validation
25. MARKET OPPORTUNITIES FOR GLYCATED HAEMOGLOBIN TESTING IN MIDDLE EAST & AFRICA (MEA)
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Revenue Shift Analysis
25.4. Market Movement Analysis
25.5. Penetration-Growth (P-G) Matrix
25.6. Glycated Haemoglobin Testing Market in Middle East and Africa (MEA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.1. Glycated Haemoglobin Testing Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.2. Glycated Haemoglobin Testing Market in Iran: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.3. Glycated Haemoglobin Testing Market in Iraq: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.4. Glycated Haemoglobin Testing Market in Israel: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.5. Glycated Haemoglobin Testing Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.6. Glycated Haemoglobin Testing Market in South Africa: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.7. Glycated Haemoglobin Testing Market in United Arab Emirates: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.7. Data Triangulation and Validation
26. MARKET OPPORTUNITIES FOR GLYCATED HAEMOGLOBIN TESTING IN LATIN AMERICA
26.1. Chapter Overview
26.2. Key Assumptions and Methodology
26.3. Revenue Shift Analysis
26.4. Market Movement Analysis
26.5. Penetration-Growth (P-G) Matrix
26.6. Glycated Haemoglobin Testing Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.1. Glycated Haemoglobin Testing Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.2. Glycated Haemoglobin Testing Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.7. Data Triangulation and Validation
27. ADJACENT MARKET ANALYSIS
28. KEY WINNING STRATEGIES
29. SWOT ANALYSIS
30. ROOTS STRATEGIC RECOMMENDATIONS
31. INSIGHTS FROM PRIMARY RESEARCH
32. REPORT CONCLUSION
33. TABULATED DATA
34. LIST OF COMPANIES AND ORGANIZATIONS
35. CUSTOMIZATION OPPORTUNITIES
36. ROOTS SUBSCRIPTION SERVICES
37. AUTHOR DETAILS